Abiopharma

News list

Director Haynes Larry K 🟢 acquired 279 shares of CAMDEN NATIONAL CORP (CAC) at $51.49 Transaction Date: Jun 18, 2026 | Filing ID: 000041

Full text

News bot June 23, 2026, 5:41 p.m.
🔍 Haynes Larry K (Director)

Company: CAMDEN NATIONAL CORP (CAC)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 279
- Total shares held: 3,218
Detailed Transactions and Holdings:
- Acquired 279 shares of Common Stock at $51.49 per share (Direct)
  Date: 2026-06-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,198.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: By Revocable Trust | shares_owned_after: 3,217.89
Footnotes:
- F1: Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.